204
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

, , , &
Pages 347-353 | Published online: 08 Nov 2016

Figures & data

Table 1 Baseline demographic and clinical characteristics of all patients

Figure 1 Use of teneligliptin.

Abbreviations: Met, metformin; SU, sulfonylureas; Teneli, teneligliptin.
Figure 1 Use of teneligliptin.

Table 2 Mean reduction in glycemic parameters compared to baseline

Figure 2 Mean reduction in glycemic parameters at the end of 3 months.

Notes:P-value <0.0001 for all glycemic parameters in all subgroups.
Abbreviations: FPG, fasting plasma glucose; PPG, postprandial plasma glucose; SU, sulfonylureas.
Figure 2 Mean reduction in glycemic parameters at the end of 3 months.